US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Patent 7959925 was granted and assigned to Providence Health System on June, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 13, 2009
Date of Patent
June 14, 2011
Patent Application Number
12618678
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
